Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis

Objective This prospective study was designed to analyze the incidence and the factors associated with impairment in left ventricular systolic function (LVSF) overtime in patients with rheumatoid arthritis (RA) without overt cardiac disease. In particular, we verified the hypothesis that a relations...

Full description

Bibliographic Details
Main Authors:	Giovanni Cioffi, Alessandro Giollo, Giovanni Orsolini, Luca Idolazzi, Andrea Dalbeni, Federica Ognibeni, Elena Fracassi, Davide Gatti, Angelo Fassio, Maurizio Rossini, Ombretta Viapiana
Format:	Article
Language:	English
Published:	Wiley 2020-04-01
Series:	ACR Open Rheumatology
Online Access:	https://doi.org/10.1002/acr2.11119

Similar Items

Association between environmental air pollution and rheumatoid arthritis flares
by: Giovanni Adami, et al.
Published: (2021-04-01)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
by: Giovanni Orsolini, et al.
Published: (2018-10-01)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
by: Giovanni Orsolini, et al.
Published: (2018-11-01)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
by: Eugenia Bertoldo, et al.
Published: (2021-05-01)

Risk of fracture in patients with glucocorticoid requiring diseases
by: Giovanni Adami, et al.
Published: (2021-04-01)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
by: Denise Rotta, et al.
Published: (2020-12-01)

P169 RELATIONSHIP BETWEEN COMMON CAROTID DISTENSIBILITY/AORTIC STIFFNESS AND LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN RHEUMATOLOGIC PATIENTS
by: Michele Bevilacqua, et al.
Published: (2018-12-01)

Anti-CCP antibodies and bone
by: Giovanni Orsolini, et al.
Published: (2018-04-01)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
by: Giovanni Adami, et al.
Published: (2022-06-01)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
by: Giovanni Adami, et al.
Published: (2023-09-01)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
by: Giovanni Adami, et al.
Published: (2023-11-01)

Factors associated with osteoporosis care of men: A real-life study on a nation-wide dataset
by: Giovanni Adami, et al.
Published: (2021-04-01)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
by: Giovanni Adami, et al.
Published: (2023-01-01)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
by: Angelo Fassio, et al.
Published: (2022-09-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Changes in bone turnover markers and bone modulators during abatacept treatment
by: Giovanni Adami, et al.
Published: (2023-10-01)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
by: Giovanni Adami, et al.
Published: (2022-03-01)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
by: Riccardo Bixio, et al.
Published: (2022-11-01)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
by: Angelo Fassio, et al.
Published: (2020-05-01)

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study
by: Angelo Fassio, et al.
Published: (2021-07-01)

Temporal trends and factors associated with vitamin D prescription and intake
by: Giovanni Adami, et al.
Published: (2021-04-01)

Anticitrullin antibodies modern markers of rheumatoid arthritis
by: Natal'ya Petrovna Shilkina, et al.
Published: (2011-01-01)

The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis
by: A. Fassio, et al.
Published: (2016-09-01)

A case of mandible Paget’s disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016-12-01)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
by: Giovanni Adami, et al.
Published: (2022-03-01)

Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study
by: Giorgio Faganello, et al.
Published: (2018-06-01)

Effects of secukinumab on serum adipocytokines: preliminary data
by: A. Fassio, et al.
Published: (2017-09-01)

Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
by: G. Adami, et al.
Published: (2020-07-01)

Insight into the WNT system and its drug related response
by: S. Tamanini, et al.
Published: (2013-12-01)

Vitamin D and fractures: a sistematic review
by: L. Idolazzi, et al.
Published: (2011-09-01)

Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study
by: Alessandro Giollo, et al.
Published: (2022-08-01)

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
by: G. Adami, et al.
Published: (2023-05-01)

Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
by: Angelo Fassio, et al.
Published: (2022-11-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

Vitamin D and rheumatic diseases
by: M. Rossini, et al.
Published: (2014-07-01)

Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis.
by: Fisher, B, et al.
Published: (2012)

Anticitrullinated antibodies recognize rheumatoid arthritis associated T-cell epitopes modified by bacterial L-asparaginase
by: Tsvetelina Batsalova, et al.
Published: (2023-09-01)

Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis
by: Hernández Raquel, et al.
Published: (2012-11-01)